Anna-maria S. Dittrich

Anna-maria S. Dittrich

Carl Neuberg Str 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Effects of elexacaftor/tezacaftor/ivacaftor on the nasal microbial metagenome in cystic fibrosis.

Effects of elexacaftor/tezacaftor/ivacaftor on the nasal microbial metagenome in cystic fibrosis.

Journal: Microbiology spectrum

Published: July 13, 2026

Frequency and Clinical Relevance of Residual Bronchodilator Responsiveness in Adults with Asthma.

Frequency and Clinical Relevance of Residual Bronchodilator Responsiveness in Adults with Asthma.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 04, 2026

Increased high sensitivity C-reactive protein in more severe wheeze/asthma phenotypes in child- and adulthood in ALLIANCE.

Increased high sensitivity C-reactive protein in more severe wheeze/asthma phenotypes in child- and adulthood in ALLIANCE.

Journal: Respiratory research

Published: May 04, 2026

Nasal Epithelial Immune Signatures Are Associated With Age-Dependent Asthma Trajectories in Early Life.

Nasal Epithelial Immune Signatures Are Associated With Age-Dependent Asthma Trajectories in Early Life.

Journal: Allergy

Published: March 09, 2026

Whole-blood CD3/CD28-stimulated cytokine responses in children with preschool wheeze, asthma, and healthy controls.

Whole-blood CD3/CD28-stimulated cytokine responses in children with preschool wheeze, asthma, and healthy controls.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: January 20, 2026

Pulmonary imaging of cystic fibrosis with a focus on children and adolescents

Pulmonary imaging of cystic fibrosis with a focus on children and adolescents

Journal: Radiologie (Heidelberg, Germany)

Published: October 02, 2025

Type 3 innate lymphoid cells dominate the ILC compartment in endstage lung disease.

Type 3 innate lymphoid cells dominate the ILC compartment in endstage lung disease.

Journal: Frontiers in immunology

Published: September 30, 2025

B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.

B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.

Journal: Respiratory research

Published: September 10, 2025

First European Results of Shape-Sensing Robotic-Assisted Bronchoscopy.

First European Results of Shape-Sensing Robotic-Assisted Bronchoscopy.

Journal: Respiration; international review of thoracic diseases

Published: September 08, 2025

SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease.

SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease.

Journal: Scientific reports

Published: September 01, 2025

Exploring trends and predictors of long-term asthma remission.

Exploring trends and predictors of long-term asthma remission.

Journal: The World Allergy Organization journal

Published: July 15, 2025

Safety and Feasibility of the Lung Volume Reduction Reverser System in Patients with Severe Emphysema: A First-in-Human Pilot Study.

Safety and Feasibility of the Lung Volume Reduction Reverser System in Patients with Severe Emphysema: A First-in-Human Pilot Study.

Journal: Respiration; international review of thoracic diseases

Published: July 10, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026